Angiomyofibroblastoma
This article may be too technical for most readers to understand. (May 2014) |
Angiomyofibroblastoma is an uncommon benign mesenchymal tumor. It occurs almost in the vulvovaginal area of women, but can also be observed in men.
The gross features of AMFB are well-circumscribed. Usually, most tumors grow slowly, and patients do not feel pain. It also has low tendency for local recurrence.
Location[edit]
- In women
- In men
Pathology[edit]
Microscopical examination shows abundant thin-walled blood vessels with hypocellular and hypercellular areas.
Immunohistochemistry[edit]
Almost all tumor cells have immunoreactivity for both desmin and vimentin. It also express estrogen receptors and/or progesterone receptors, but staining for cytokeratin is negative.[5]
References[edit]
- ↑ "Clinicopathologic analysis of angiomyofibroblastoma of the female genital tract".Chinese Medical Journal.2000;113(11)
- 1036–9.PMID:11776120.
- ↑ "Angiomyofibroblastoma of the vulva".Obstetrics & Gynecology Science.2013;56(5)
- 349–51.doi:10.5468/ogs.2013.56.5.349.PMID:24328028.PMC:3784123.
- ↑ "Angiomyofibroblastoma arising from the posterior perivesical space: A case report with MR findings".Korean Journal of Radiology.2008;9(4)
- 382–5.doi:10.3348/kjr.2008.9.4.382.PMID:18682679.PMC:2627271.
- ↑ "Angiomyofibroblastoma of the spermatic cord: A case report".Journal of Medical Case Reports.2010;4
- 79.doi:10.1186/1752-1947-4-79.PMID:20202207.PMC:2838917.
- ↑ "Angiomyofibroblastoma of the vulva".Obstetrics & Gynecology Science.2013;56(5)
- 349–51.doi:10.5468/ogs.2013.56.5.349.PMID:24328028.PMC:3784123.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian